시장보고서
상품코드
1614874

세계의 PBM(Pharmacy Benefit Management) 시장 규모, 점유율 및 성장 분석 : 서비스별, 비즈니스 모델별, 최종 사용자별, 지역별 - 산업 예측(2024-2031년)

Pharmacy Benefit Management Market Size, Share, Growth Analysis, By Type (Specialty Pharmacy, Drug Formulatory Management), By Business Model, By End User, By Region - Industry Forecast 2024-2031

발행일: | 리서치사: SkyQuest | 페이지 정보: 영문 157 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 PBM(Pharmacy Benefit Management) 시장 규모는 2022년 5,068억 달러, 2023년 5,403억 달러에서 2031년 8,742억 달러에 이르고 예측 기간(2024-2031년) 동안 6.2%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다.

PBM(Pharmacy Benefit Management) 시장은 약물 오남용 감소에 대한 수요 증가, 약국의 급속한 지역화, 고령화, 인건비 증가 등 다양한 요인으로 인해 강력한 성장세를 보이고 있으며, PBM은 의약품 처방 관리, 리베이트 협상, 보험사 및 약국의 처방약 프로그램 감독 등 의약품 공급망에서 중요한 역할을 담당하고 있습니다. 의약품 공급망에서 중요한 역할을 담당하고 있습니다. 그러나 약국의 자동화 기술 도입에 대한 주저함, 고객 기밀 유지에 대한 엄격한 규제 등이 시장 발전을 저해하는 요인으로 작용할 수 있습니다. 반면, 비용 절감 전략과 PBM 서비스의 이점에 대한 약사 및 의료 서비스 제공업체의 인식이 높아짐에 따라 예측 기간 동안 시장 확대에 큰 기회가 될 수 있습니다. 전반적으로 PBM 분야는 향후 몇 년동안 괄목할 만한 발전을 이룰 준비가 되어 있습니다.

목차

서론

  • 조사 목적
  • 조사 범위
  • 정의

조사 방법

  • 정보 조달
  • 2차/1차 정보원
  • 시장 규모 예측
  • 시장 전제조건과 제한

주요 요약

  • 세계 시장 전망
  • 공급과 수요 동향 분석
  • 부문별 기회 분석

시장 역학과 전망

  • 시장 개요
  • 시장 규모
  • 시장 역학
    • 성장 촉진요인과 기회
    • 성장 억제요인과 과제
  • Porter의 Five Forces 분석과 영향
    • 경쟁 기업간 경쟁 관계
    • 대체품의 위협
    • 바이어의 교섭력
    • 신규 진출업체의 위협
    • 공급 기업의 교섭력

주요 시장 인사이트

  • 중요 성공 요인
  • 경쟁 정도
  • 주요 투자 기회
  • 시장 생태계
  • 기술 진보
  • 규제 상황
  • 특허 분석
  • 밸류체인 분석
  • PESTEL 분석
  • 시장의 매력 지수

PBM(Pharmacy Benefit Management) 시장 규모 : 서비스별, CAGR(2024년-2031년)

  • 시장 개요
  • 전문 약국
  • 의약품 처방 관리
  • 복리후생 플랜 설계 및 컨설팅
  • 기타 서비스

PBM(Pharmacy Benefit Management) 시장 규모 : 비즈니스 모델별, CAGR(2024년-2031년)

  • 시장 개요
  • 정부 건강 프로그램
  • 고용주 후원 프로그램
  • 건강보험 관리

PBM(Pharmacy Benefit Management) 시장 규모 : 최종사용자별, CAGR(2024년-2031년)

  • 시장 개요
  • PBM(Pharmacy Benefit Management) 조직
  • 통신 판매 약국
  • 소매 약국
  • 기타 최종사용자

PBM(Pharmacy Benefit Management) 시장 규모, CAGR(2024년-2031년)

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 스페인
    • 프랑스
    • 이탈리아
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • GCC 국가
    • 남아프리카공화국
    • 기타 중동 및 아프리카

경쟁 정보

  • 주요 5개사 비교
  • 주요 기업의 시장 포지셔닝(2023년)
  • 주요 시장 기업이 채택한 전략
  • 시장 최근 동향
  • 기업의 시장 점유율 분석(2023년)
  • 주요 기업 개요
    • 기업 개요
    • 제품 포트폴리오 분석
    • 부문별 점유율 분석
    • 매출 전년대비 비교(2021년-2023년)

주요 기업 개요

  • Express Scripts Holding Company
  • CVS Health Corporation
  • OptumRx, Inc.
  • Prime Therapeutics LLC
  • Humana Pharmacy Solutions, Inc.
  • MedImpact Healthcare Systems, Inc.
  • Magellan Health, Inc.
  • Cigna Corporation
  • Aetna Inc.
  • Anthem, Inc.
  • UnitedHealth Group Incorporated
  • WellDyneRx, LLC
  • Navitus Health Solutions, LLC
  • PerformRx, LLC
  • EnvisionRxOptions, LLC
  • IngenioRx, Inc.
  • Argus Health Systems, Inc.
  • ScriptCare, Ltd.
  • Catalyst Rx, Inc.
  • Curascript Specialty Distribution, Inc.

결론과 추천 사항

LSH 25.01.08

Global Pharmacy Benefit Management Market size was valued at USD 506.8 billion in 2022 and is poised to grow from USD 540.3 billion in 2023 to USD 874.2 billion by 2031, growing at a CAGR of 6.2% during the forecast period (2024-2031).

The Pharmacy Benefit Management (PBM) market is experiencing robust growth driven by various factors, including the rising demand for reducing medication errors, the rapid regionalization of pharmacies, an aging population, and increasing labor costs. PBMs play a critical role in the pharmaceutical supply chain, managing drug formularies, negotiating rebates, and overseeing prescription drug programs for insurers and pharmacies. However, challenges such as hesitance to adopt pharmacy automation technologies and stringent regulations on client confidentiality may hinder market progress. Conversely, heightened awareness among pharmacists and healthcare providers about the benefits of cost-reduction strategies and PBM services presents significant opportunities for market expansion throughout the forecast period. Overall, the PBM sector is poised for remarkable development in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmacy Benefit Management market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pharmacy Benefit Management Market Segmental Analysis

Global Pharmacy Benefit Management Market is segmented by Services, Business Model, End User and Region. Based on Services, the market is segmented into specialty pharmacy, drug formulatory management, benefit plan design & consultation and other services. Based on Business Model, the market is segmented into Government Health Programs, Employer-Sponsored Programs, and Health Insurance Management. Based on End Users, the market is segmented into pharmacy benefit management organization, mail order pharmacies, retail pharmacies, and other end users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pharmacy Benefit Management Market

The Global Pharmacy Benefit Management market is experiencing significant growth due to escalating pharmaceutical costs driven by the rising incidence of chronic diseases worldwide. As chronic conditions such as cardiovascular disease and chronic lung disease become more prevalent, there is an increasing demand for effective treatment options. This trend has prompted major pharmaceutical companies to develop high-priced branded medications, leading to an unprecedented surge in drug expenditures. Consequently, the soaring healthcare costs associated with an uptick in prescription registrations create a substantial financial burden. This scenario drives the demand for pharmacy benefit management services, which aim to mitigate drug expenses and regulate pharmaceutical spending on a global scale, facilitating market expansion.

Restraints in the Global Pharmacy Benefit Management Market

The Global Pharmacy Benefit Management market faces significant restraints due to a lack of transparency regarding profit earnings, which hinders widespread adoption. While rising medication costs and increased prescription filings globally are contributing to market growth, concerns about the opacity of business models within pharmacy benefit management services remain a persistent issue. The revenue streams of these services are often undisclosed to insurance providers, retail pharmacies, and pharmaceutical manufacturers, resulting in substantial medication costs being transferred to service providers. Consequently, both drug manufacturers and insurers are experiencing notable declines in profits, leading many insurers to form limited partnerships with pharmacy benefit managers. This situation contributes to a slow adoption rate of these services, which is anticipated to restrain market growth throughout the study period.

Market Trends of the Global Pharmacy Benefit Management Market

The Global Pharmacy Benefit Management (PBM) market is undergoing a significant transformation driven by the adoption of machine learning technologies, which streamline operations and enhance service delivery. As insurance companies, retail pharmacy chains, and drug manufacturers increasingly embrace PBM services, there is a notable shift from traditional workflows to advanced, data-driven processes. This transition facilitates a more efficient supply chain, accelerates mail order delivery, and enables service providers to cater to a broader range of insurance plans and pharmacy networks quickly. Consequently, this trend not only improves operational efficiency but also enhances customer satisfaction, positioning machine learning as a critical component of PBM evolution.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Driver & Opportunities
    • Restraints & Challenges
  • Porters Analysis & Impact
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Technological Advancement
  • Regulatory Landscape
  • Patent Analysis
  • Value Chain Analysis
  • PESTEL Analysis
  • Market Attractiveness Index

Global Pharmacy Benefit Management Market Size by Services & CAGR (2024-2031)

  • Market Overview
  • Specialty Pharmacy
  • Drug Formulatory Management
  • Benefit Plan Design and Consultation
  • Other Services

Global Pharmacy Benefit Management Market Size by Business Model & CAGR (2024-2031)

  • Market Overview
  • Government Health Programs
  • Employer-Sponsored Programs
  • Health Insurance Management

Global Pharmacy Benefit Management Market Size by End User & CAGR (2024-2031)

  • Market Overview
  • Pharmacy Benefit Management Organization
  • Mail Order Pharmacies
  • Retail Pharmacies
  • Other End Users Source

Global Pharmacy Benefit Management Market Size & CAGR (2024-2031)

  • North America (Services, Business Model, End-User)
    • US
    • Canada
  • Europe (Services, Business Model, End-User)
    • UK
    • Germany
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Asia-Pacific (Services, Business Model, End-User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America (Services, Business Model, End-User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Services, Business Model, End-User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Express Scripts Holding Company
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CVS Health Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • OptumRx, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Prime Therapeutics LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Humana Pharmacy Solutions, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MedImpact Healthcare Systems, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Magellan Health, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cigna Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Aetna Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Anthem, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • UnitedHealth Group Incorporated
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • WellDyneRx, LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Navitus Health Solutions, LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PerformRx, LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • EnvisionRxOptions, LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • IngenioRx, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Argus Health Systems, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ScriptCare, Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Catalyst Rx, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Curascript Specialty Distribution, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendation

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제